HotSpot Therapeutics
PrivateLast Round
Series C
Nov 29, 2021
Total Funding Raised
$210M
Company Overview
HotSpot Therapeutics is a biotechnology company that pioneers allosteric drug discovery by identifying and targeting natural regulatory hotspots on proteins to develop differentiated small molecule medicines for autoimmune diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HotSpot Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
HotSpot Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 29, 2021 | ||||
| Series B | May 21, 2020 | ||||
| Series A | Jul 17, 2018 |
Key People
Founding team and executive leadership
HotSpot Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brace Pharma Capital | Series B |
| EQT Life Sciences | Series C |
| B Capital Group | Series C |
| Pivotal bioVenture Partners | Series C |
| Tekla Capital Management | Series B, Series C |
| Nan Fung Group | Series C |
| Solasta Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Presented preclinical data at the 15th European Lupus Meeting.
- Mar 4, 2026
Launched interferon regulatory factor 5 (IRF5) program with preclinical data.
HotSpot Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HotSpot Therapeutics's valuation, stock price, and market status.